LAVA Therapeutics NV (LAVA Therapeutics NV) Scaled Net Operating Assets : -0.34 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is LAVA Therapeutics NV Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

LAVA Therapeutics NV's operating assets for the quarter that ended in Dec. 2023 was $6.14 Mil. LAVA Therapeutics NV's operating liabilities for the quarter that ended in Dec. 2023 was $44.22 Mil. LAVA Therapeutics NV's Total Assets for the quarter that ended in Sep. 2023 was $111.02 Mil. Therefore, LAVA Therapeutics NV's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2023 was -0.34.

LAVA Therapeutics NV Scaled Net Operating Assets Historical Data

The historical data trend for LAVA Therapeutics NV's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LAVA Therapeutics NV Scaled Net Operating Assets Chart

LAVA Therapeutics NV Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

0.03

-0.47

-0.49

-0.30

-0.27

LAVA Therapeutics NV Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Scaled Net Operating Assets	Get a 7-Day Free Trial												-0.28	-0.30	-0.31	-0.36	-0.34

Competitive Comparison of LAVA Therapeutics NV's Scaled Net Operating Assets

For the Biotechnology subindustry, LAVA Therapeutics NV's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LAVA Therapeutics NV's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LAVA Therapeutics NV's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where LAVA Therapeutics NV's Scaled Net Operating Assets falls into.

LAVA Therapeutics NV Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

LAVA Therapeutics NV's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(6.139	-	44.219)	/	143.425
=	-0.27

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	101.71	-	95.571
=	6.139

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	50.532	-	0.591	-	5.722
=	44.219

LAVA Therapeutics NV's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2023 )
=	(Operating Assets (Q: Dec. 2023 )	-	Operating Liabilities (Q: Dec. 2023 ))	/	Total Assets (Q: Sep. 2023 )
=	(6.139	-	44.219)	/	111.02
=	-0.34

where

	Operating Assets		(Q: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	101.71	-	95.571
=	6.139

	Operating Liabilities		(Q: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	50.532	-	0.591	-	5.722
=	44.219

LAVA Therapeutics NV Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of LAVA Therapeutics NV's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

LAVA Therapeutics NV (LAVA Therapeutics NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LAVA Therapeutics NV (NAS:LVTX) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

4PKB:Germany

Address

Yalelaan 62, Utrecht, UT, NLD, 3584 CM

Website

https://www.lavatherapeutics.com

LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells.